Coffee consumption is associated with a lower risk of recurrence of prostate cancer, according to a study by researchers at Fred Hutchinson Cancer Research Center, USA, advances the portal Isaúde.
The results show that bioactive compounds in coffee and tea can prevent the disease returning and delay its progression.
The leader of the research, Janet L. Stanford and his colleagues found that men who drank four or more cups of coffee per day experienced a 59% reduction in the risk of prostate cancer recurrence and/or progression compared with those who drank only one or less cups week.
The study involved 1,001 survivors of prostate cancer, aged 35 and 74 years of age at diagnosis between 2002 and 2005.
Participants answered questions about their diet and consumption of alcoholic two years before the diagnosis of prostate cancer using a food frequency questionnaire and were interviewed about demographic and lifestyle, family history of cancer and drug use.
Of the participants, 630 responded to questions related to coffee intake, embedded on the monitoring criteria and were included in the final analysis. Of these, 61% of men consumed at least one cup of coffee per day and 12% consumed a larger amount: four or more cups per day.
"Our study differs from previous use as a setting composed of recurrence and progression of prostate cancer. Using detailed data, we can determine if a patient's has risk of recurrence or progression of prostate cancer," says first author Milan Geybels.
According to investigators, the biological activities associated with the consumption of phyto-chemical compounds found in coffee include anti-inflammatories and antioxidants, besides the modulation of glucose metabolism.
Despite promising results, the team highlights the coffee or components thereof may not yet be recommended for secondary prevention of prostate cancer before its preventive effect is demonstrated in a clinical study.
Source: Portal de Oncologia Português